Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Pharmaceutical Business Review
Return to: PBR Home | Suppliers

Early Stage Clinical Research Solutions

Celerion is the premier provider of innovative early stage clinical research solutions.

Formed through the acquisition of the early stage development operations of MDS Pharma Services, Celerion has a full spectrum of resources to meet the needs of the pharmaceutical, biotechnology and generic industries for Phase 0 through IIa proof-of-concept studies. From facilities strategically located around the world, advanced scientific and technological expertise is applied to:

  • Clinical research: phase 0, I and IIa, NDA-enabling clinical pharmacology, and ADME
  • Clinical pharmacology sciences: modeling and simulation, study design and protocol development, sata management, biostatistics, and PK/PD and medical writing and reporting
  • Bioanalytical services, including discovery through late stage
  • Drug development services

Celerion's focus is on the implementation of innovative strategies to generate key data very early to enable go/no-go decisions on drug development. With a clinical capacity of more than 730 beds (24 in-hospital), efficient bioanalytical laboratories and experienced scientific staff, Celerion offers one of the most experienced clinical pharmacology research networks in the industry.

Celerion's combination of experienced people, scientific excellence and state-of-the-art facilities strongly positions the company as the industry leader in the conduct of early clinical research and bioanalytical studies.

pic 1

Contact details:

Celerion
621 Rose St.
Lincoln, NE 68502
+1.402.476.2811
info@celerion.com
www.celerion.com

As a registered user of PBR you can skip the majority of this form. Registration is FREE so register now or log in if you're already a member.
Request Further Information
Fill In Details

Complete a quick security check and confirm terms and conditions

This step helps prevent unfair use of automated programs.
I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, or if you would prefer not to receive these, uncheck this box.
If you would prefer not to hear from carefully selected third party companies uncheck this box



By clicking the 'Request Information' button you agree to pass your details as shown to the white paper advertiser. The enquirer also permits the advertiser to follow up the enquiry by phone or letter. PBR is in no way responsible for further communication between parties.
Fields marked * are compulsory